Sustained clinical inactivity and stabilization of GH/IGF-1 levels in an acromegalic patient after discontinuation of somatostatin analogue treatment

Endocrine Journal

Volumn 55, Issue 2, 2008, Pages 351-357

  Avramidis, Avraam ^a   Polyzos, Stergios A ^a   Efstathiadou, Zoe ^a   Kita, Marina ^a  

^a Aristotle University of Thessaloniki   (Greece)

Author keywords

Acromegaly; Growth hormone (GH); Insulin like growth factor 1 (IGF 1); Pituitary adenoma; Somatostatin analogues

Indexed keywords

BROMOCRIPTINE; GROWTH HORMONE; OCTREOTIDE; PREDNISOLONE; SOMATOMEDIN C;

ACROMEGALY; ADULT; ARTHRALGIA; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FATIGUE; FEMALE; FOOT MALFORMATION; GALACTORRHEA; HAND PARESTHESIA; HUMAN; HYPOPHYSIS ADENOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGOMENORRHEA; ORAL GLUCOSE TOLERANCE TEST; PATIENT COMPLIANCE; PROGNATHIA; PROTEIN STABILITY; TRANSSPHENOIDAL SURGERY; TREATMENT DURATION;

ACROMEGALY; ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLUCOSE TOLERANCE TEST; GROWTH HORMONE; HORMONES; HUMANS; INSULIN-LIKE GROWTH FACTOR I; SOMATOSTATIN;

EID: 43449097570     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K07E-055     Document Type: Article

References (39)